![Geoffrey A. Strange](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profile
Geoffrey A. Strange is currently the Chief Research & Strategy Officer at EchoIQ Ltd. and the Chief Medical Officer at LTR Pharma Ltd. Previously, he served as the Chief Executive Officer of The Pulmonary Hypertension Society of Australia & New Zealand from 2009 to 2021.
He also worked as the Global Medical Director at Anteris Technologies Ltd.
Geoffrey A. Strange active positions
| Companies | Position | Start |
|---|---|---|
| VERILUMA | Chief Tech/Sci/R&D Officer | - |
| LTR PHARMA LIMITED | Chief Tech/Sci/R&D Officer | - |
Former positions of Geoffrey A. Strange
| Companies | Position | End |
|---|---|---|
The Pulmonary Hypertension Society of Australia & New Zealand | Chief Executive Officer | 2021-05-31 |
Anteris Technologies Ltd.
 Anteris Technologies Ltd. Medical SpecialtiesHealth Technology Develops and commercializes technologies for heart valves | Chief Tech/Sci/R&D Officer | - |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 4 |
|---|---|
Anteris Technologies Ltd.
Anteris Technologies Ltd. Medical SpecialtiesHealth Technology Develops and commercializes technologies for heart valves | Health Technology |
The Pulmonary Hypertension Society of Australia & New Zealand | |
EchoIQ Ltd.
 EchoIQ Ltd. Other Metals/MineralsNon-Energy Minerals Develops and commercializes software products | Non-Energy Minerals |
Ltr Pharma Ltd.
 Ltr Pharma Ltd. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company | Health Technology |
- Stock Market
- Insiders
- Geoffrey A. Strange
